LifeStance Health Group, Inc. (LFST) Market Cap & Valuation Ratios
LifeStance Health Group, Inc. (LFST) has a market cap of $4.9B, a trailing P/E of 99.7 and a price-to-sales ratio of 3.1, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LFSTLifeStance Health Group, Inc.Follow LFST — free
—
Price chart with a free account
- Market cap
- 4.9B
- P/E TTM
- 99.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Peers
medical care facilities · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| LFST | 4.9 | 99.7 | 3.1 | 37.4 | 3.5% | +20% | 5% | 4% |
| ENSG | 10 | 27.5 | 1.8 | 17.3 | 4.1% | +19% | 9% | 17% |
| PACS | 7.5 | 27.9 | 1.4 | 15.9 | 6.0% | +15% | 7% | 29% |
| CHE | 6.7 | 25.8 | 2.6 | 16.4 | 4.8% | +3% | 13% | 28% |
| CON | 5.0 | 25.3 | 2.8 | 14.1 | 5.3% | +14% | 16% | 15% |
| OPCH | 4.7 | 23.7 | 1.0 | 13.9 | 6.5% | +6% | 6% | 11% |
| NHC | 3.7 | 26.6 | 2.3 | 19.2 | 4.0% | +7% | 9% | 11% |
| ACHC | 2.9 | — | 1.5 | — | -4.6% | +4% | -28% | -20% |
| AVAH | 2.9 | — | 1.6 | 15.0 | 5.4% | +20% | 11% | 13% |
| GRDN | 2.5 | 38.7 | 1.6 | 22.1 | 3.0% | +10% | 6% | 38% |
| BKD | 2.4 | — | 2.1 | 14.5 | 0.0% | -4% | 3% | 2% |
| Median of these 10 | 26.6 | 1.7 | 15.9 | 4.5% | +9% | 8% | 14% |
P/E 99.7 vs. a peer median of 26.6; EV/Sales 3.1 vs. 1.7.
Growth vs. price
each dot a company · hover or tap for valuesACHC and AVAH and BKD have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
LifeStance Health Group, Inc. — questions
- What is LifeStance Health Group, Inc.'s market cap?
- $4.9B.
- What is LifeStance Health Group, Inc.'s P/E ratio?
- 99.7 on trailing twelve-month earnings to 2026-06-30.
- What is LifeStance Health Group, Inc.'s price-to-sales ratio?
- 3.1.
Every figure on this page comes from LifeStance Health Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.